Kenji Hara
About
In The Last Decade
Kenji Hara
347 papers receiving 7.8k citations
Peers
Comparison fields: 5 of 171
- Biomedical Engineering 1.9k
- Organic Chemistry 1.8k
- Materials Chemistry 1.3k
- Molecular Biology 892
- Epidemiology 729
Countries citing papers authored by Kenji Hara
This map shows the geographic impact of Kenji Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Hara more than expected).
Fields of papers citing papers by Kenji Hara
This network shows the impact of papers produced by Kenji Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Hara. The network helps show where Kenji Hara may publish in the future.
Co-authorship network of co-authors of Kenji Hara
This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Hara. A scholar is included among the top collaborators of Kenji Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Hara. Kenji Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | Bright-Region Gray World Assumption for Restoring Color of Objects | 0 |
| 7 | The Effect of Switching from Either Mitiglinide or Glimepiride to Repaglinide on Both Glycemic Control and Oxidative Stress in Patients with Type 2 Diabetes | 1 |
| 8 | Long Term Evaluation of Glycemic Control in Patients with Type 2 Diabetes Receiving Either Alogliptin and Lansoprazole or Alogliptin Mono-therapy for 3 Months Followed by Alogliptin Mono-therapy:A Retrospective Analysis | 4 |
| 9 | 0 | |
| 10 | Photometric Stereo beyond Glass: Active Separation of Transparent Layer and Five-Light Photometric Stereo with M-Estimator Using Laplace Distribution for a Virtual Museum | 3 |
| 11 | 1 | |
| 12 | Estimating Light Position and Surface Reflectance from Specular Reflection under Perspective Projection. | 1 |
| 13 | 5 | |
| 14 | 3 | |
| 15 | 3-D Shape Reconstruction by Using Statistical Models | 0 |
| 16 | Antifungal activity against Aspergillus fumigatus mycelial cells measured by wet weight, protein concentration and enzymatic activity | 2 |
| 17 | [A 14-year-old with pulmonary hamartomatous lymphangiomyomatosis associated with bilateral pneumothoraces]. | 1 |
| 18 | Susceptibility of the species of genus bacteroides recently isolated from clinical specimens to 20 antimicrobial agents. | 6 |
| 19 | [Serum m-GOT activity in liver disease--studies on the determination method and clinical significance (author's transl)]. | 1 |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.